Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency

MeSH terms

• Aged, 80 and over
• Anti-Bacterial Agents / adverse effects*
• Anti-Bacterial Agents / therapeutic use
• Anticoagulants / therapeutic use
• Aortic Valve Stenosis / complications
• Aortic Valve Stenosis / surgery
• Atrial Fibrillation / complications
• Atrial Fibrillation / drug therapy
• Autoantibodies / blood
• Autoantibodies / immunology*
• Autoimmune Diseases / diagnosis
• Autoimmune Diseases / immunology
• Autoimmune Diseases / therapy*
• Ceftriaxone / adverse effects*
• Ceftriaxone / therapeutic use
• Combined Modality Therapy
• Emergencies
• Factor V / immunology*
• Factor V Deficiency / diagnosis
• Factor V Deficiency / immunology
• Factor V Deficiency / therapy*
• Female
• Heart Failure / etiology
• Humans
• Partial Thromboplastin Time
• Platelet Transfusion*
• Prednisone / therapeutic use
• Preoperative Care / methods*
• Prothrombin Time
• Pyrazoles / adverse effects
• Pyrazoles / therapeutic use
• Pyridones / adverse effects
• Pyridones / therapeutic use
• Transcatheter Aortic Valve Replacement*
• Urinary Tract Infections / complications
• Urinary Tract Infections / drug therapy